These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16175594)

  • 1. Vagaries of impaired transporter function in PFIC 2 and 3.
    Ostrow JD; Tiribelli C
    Hepatology; 2005 Oct; 42(4):977-8; author reply 978. PubMed ID: 16175594
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill.
    Kortgen A; Paxian M; Werth M; Recknagel P; Rauchfuss F; Lupp A; Krenn CG; Müller D; Claus RA; Reinhart K; Settmacher U; Bauer M
    Shock; 2009 Oct; 32(4):358-65. PubMed ID: 19197231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A review on regulation of drug transporters during inflammation].
    Zeng H; Bi HC; Huang M
    Yao Xue Xue Bao; 2011 Jul; 46(7):773-9. PubMed ID: 22010345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S; Le Vee M; Jouan E; Fardel O
    J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
    Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of genetic backgrounds on hyperbilirubinemia in radixin-deficient mice due to different expression levels of Mrp3.
    Fukumoto K; Kikuchi S; Itoh N; Tamura A; Hata M; Yamagishi H; Tsukita S; Tsukita S
    Biochim Biophys Acta; 2007 Mar; 1772(3):298-306. PubMed ID: 17204408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
    Grime K; Paine SW
    Drug Metab Dispos; 2013 Feb; 41(2):372-8. PubMed ID: 23139379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of membrane transport of vitamin E.
    Takada T; Suzuki H
    Mol Nutr Food Res; 2010 May; 54(5):616-22. PubMed ID: 20205193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
    Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
    Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
    Hofman J; Kučera R; Neumanova Z; Klimes J; Ceckova M; Staud F
    Xenobiotica; 2016; 46(5):416-23. PubMed ID: 26364927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.
    Kerb R; Hoffmeyer S; Brinkmann U
    Pharmacogenomics; 2001 Feb; 2(1):51-64. PubMed ID: 11258197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
    Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
    Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.
    Zollner G; Thueringer A; Lackner C; Fickert P; Trauner M
    Digestion; 2014; 90(2):81-8. PubMed ID: 25196354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.